Loading...
FDA drug summaries: a simplification too far?
Author
Advisor
Date
2015-06-12
Embargo until
Language
Book title
Journal
Publisher
BMJ Publishing Group
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Files
Other Titles
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
The FDA has launched a new tool to help patients understand a drug’s risks and benefits. However, Peter Doshi speculates that in an effort to keep the content simple important information is being left out
Series/Report No.
Sponsors
Rights/Terms
Citation
Doshi, P. (2015). FDA drug summaries: a simplification too far? BMJ 2015;350:h3135. DOI: https://doi.org/10.1136/bmj.h3135